Research aimed at improving long-term outlook for stroke patients

The long-term consequences of a stroke often are more severe than the attack itself, a medical reality that researcher Shaohua Yang, PhD, MD, hopes to alter.

"A stroke is like an earthquake," said Dr. Yang, Associate Professor of Pharmacology and Neuroscience at UNTHSC. "It triggers a lot of other problems downstream."

Brain damage, loss of motor function and long-term disability are among the problems suffered by more than 800,000 stroke patients each year. About 25 percent to 30 percent of stroke survivors develop dementia, often within the first year of recovery. Having a stroke doubles the risk of developing dementia.

Dr. Yang, who recently received a $1.6 million grant from the National Institute of Neurological Disorders and Stroke, hopes to improve the long-term outlook for stroke patients by studying how a specific molecule called  a neuroglobin makes the brain less susceptible to stroke.

Studies have shown that an increase in neoglobin in the brain leads to less damage in an ischemic stroke, which occurs when an artery to the brain is block and accounts for 88 percent of all strokes.

"We believe that this molecule plays a major role in brain metabolism," he said. "By manipulating this molecule, we hope to find new treatments that could slow down or prevent dementia and other functional deficits following a stroke."

Over the last two decades, the treatment for ischemic stroke has improved with the delivery of the drug tPA. It is the only drug approved to dissolve blood clots that cause most strokes. But tPA must be administered intravenously and only works if given within three hours after the onset of stroke symptoms.

"Few patients get to the hospital in time to qualify for the drug," Dr. Yang said.

Patients are often disqualified from receiving the drug because they delayed going to the hospital or failed to recognize the symptoms of a stroke.

As part of Dr. Yang’s research, he is trying to identify a neuropathway that may prevent or at least provide protection against both the primary and secondary brain damage triggered by a stroke.

"If we can identify the pathway, we can develop new drugs to treat strokes and improve recovery," he said. "Our hope then is to expand treatment to other diseases."

Recent News

4ce85696 80cc 4bc6 B20b 8e48bc261e0a
  • Our People
|Apr 26, 2024

College of Pharmacy students land dream fellowships

Rachel Clark, Sulin Kamt, Haley McKeefer and Elise Vo might be nearing the end of their time at The University of North Texas Health Science Center at Fort Worth’s UNT System College of Pharmacy, but their time learning what the pharmaceutical industry has to offer is far from over. After graduati...
Dharamsi Cropped
  • Our People
|Apr 26, 2024

School of Public Health Climbs in U.S. News & World Report Rankings

The University of North Texas Health Science Center at Fort Worth’s School of Public Health is climbing the ranks in the latest U.S. News & World Report rankings of public health schools. SPH jumped four spots in this year’s rankings to number 88. This rise in the rankings reflects SPH's co...
Mtawndy2mze
  • Community
|Apr 25, 2024

New TCOM-affiliated internal medicine residency at Paris Regional Health Gains ACGME approval

In a significant move to help address the growing primary care physician shortage in Texas, The University of North Texas Health Science Center at Fort Worth’s Texas College of Osteopathic Medicine and Paris Regional Health are now approved for a new Internal Medicine Residency Program. The Accre...
Amanda
  • On Campus
|Apr 24, 2024

HSC to host HIV Symposium

HIV remains a major global health issue, with an estimated 40 million people living with HIV worldwide. About 10 million of them, including about half of infected children, do not have access to treatment. From 9:30 a.m. to noon on Monday, health care providers working on the frontlines of the HIV ...